These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1719382)

  • 1. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB
    Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
    Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS; Cai X; Abasolo I; Wang Z
    Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate.
    Labrie C; Simard J; Zhao HF; Belanger A; Pelletier G; Labrie F
    Endocrinology; 1989 Jun; 124(6):2745-54. PubMed ID: 2524377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate.
    Shao TC; Kong A; Cunningham GR
    Prostate; 1994 Apr; 24(4):212-20. PubMed ID: 7511803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment.
    Astancolle S; Guidetti G; Pinna C; Corti A; Bettuzzi S
    J Endocrinol; 2000 Nov; 167(2):197-204. PubMed ID: 11054633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of finasteride on the rat ventral prostate.
    Shao TC; Kong A; Marafelia P; Cunningham GR
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.
    Ghusn HF; Shao TC; Klima M; Cunningham GR
    J Androl; 1991; 12(5):315-22. PubMed ID: 1765567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment.
    Avila DM; Fuqua SA; George FW; McPhaul MJ
    J Endocrinol; 1998 Dec; 159(3):403-11. PubMed ID: 9834458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
    Labrie C; Trudel C; Li S; Martel C; Couêt J; Labrie F
    Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
    Fleshner NE; Trachtenberg J
    J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
    Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
    Geller J; Sionit L
    J Cell Biochem Suppl; 1992; 16H():109-12. PubMed ID: 1283893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
    Russo P; Warner JA; Huryk R; Perez G; Heston WD
    Prostate; 1994 May; 24(5):237-43. PubMed ID: 8170836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-androgen effects of the aromatase inhibitor, atamestane.
    Shao TC; Marcelli M; Kong A; Cunningham GR
    J Androl; 1995; 16(2):100-7. PubMed ID: 7559139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.
    George FW; Russell DW; Wilson JD
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8044-7. PubMed ID: 1654556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gene expression by androgen and oestrogens in the testis and prostate of the adult rat following androgen withdrawal.
    Turner KJ; Morley M; MacPherson S; Millar MR; Wilson JA; Sharpe RM; Saunders PT
    Mol Cell Endocrinol; 2001 Jun; 178(1-2):73-87. PubMed ID: 11403897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.